RxDoctor Payments Data

Caroline Buchanan

Developmental - Behavioral Pediatrics · Greenville, SCNPI 1477872810

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $136,503 of the $183,661 with a category attached, or 74.3%. Acadia Pharmaceuticals Inc accounts for 90.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $85,762 and has fallen 66.5% since, to $28,722 in 2025.

$183,661in general payments, 2019–2025

Across 230 payments — averaging $798.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$166K
  • Harmony Biosciences LLC$10K
  • Shionogi Inc$7K
  • Sanofi$62

What the payments were for

  • Consulting fees$25,71114%
  • Speaking & faculty fees$136,50374%
  • Travel & lodging$18,71610%
  • Food & beverage$2,7321%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acadia Pharmaceuticals Inc219$166,413
Harmony Biosciences LLC4$10,470
Shionogi Inc4$6,717
Sanofi3$62

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few developmental - behavioral pediatrics providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Other developmental - behavioral pediatrics in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →